OptimizeRx Corporation provided earnings guidance for the first quarter of 2024, for the quarter, the company expects revenue to increase over 40% year-over-year and come in between $18.5 million and $19.2 million with a GAAP net loss between $8.2 million - $7.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.3 USD | -2.15% | -6.61% | -14.05% |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.05% | 230M | |
+30.04% | 457B | |
+30.56% | 276B | |
+3.30% | 137B | |
+29.39% | 93.68B | |
+3.60% | 90.6B | |
+59.92% | 59.25B | |
+11.63% | 45.65B | |
+24.91% | 37.59B | |
-1.95% | 35.62B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- OptimizeRx Corporation Provides Earnings Guidance for the First Quarter of 2024